525 related articles for article (PubMed ID: 24986794)
1. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
Dasanu CA; Bockorny B; Alexandrescu DT
J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
[TBL] [Abstract][Full Text] [Related]
2. Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.
Meunier M; Larabi A; Schacherer M; Deteix C; Courby S; Cahn JY
Ann Hematol; 2020 Feb; 99(2):379-380. PubMed ID: 31822948
[No Abstract] [Full Text] [Related]
3. [Desensitization to lenalidomide].
Cañamares Orbis I; García Muñoz C; Cortijo Cascajares S; Méndez Esteban ME
Farm Hosp; 2012; 36(6):542-3. PubMed ID: 23461448
[No Abstract] [Full Text] [Related]
4. Case of multiple myeloma associated with extramedullary cutaneous plasmacytoma and pyoderma gangrenosum.
Yoon YH; Cho WI; Seo SJ
Int J Dermatol; 2006 May; 45(5):594-7. PubMed ID: 16700800
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide and its analogues: comparative clinical efficacy and safety, and cost-effectiveness.
Paumgartten FJ
Cad Saude Publica; 2014 Apr; 30(4):684-6. PubMed ID: 24896044
[No Abstract] [Full Text] [Related]
6. IgG multiple myeloma presented with ulcerative pyoderma gangrenosum.
Verrou E; Kartsios C; Banti A; Mihou D; Kaloutsi V; Lazaridou A; Zervas K
Leuk Lymphoma; 2007 Jul; 48(7):1420-2. PubMed ID: 17613774
[No Abstract] [Full Text] [Related]
7. Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective study.
Briani C; Torre CD; Campagnolo M; Lucchetta M; Berno T; Candiotto L; Padua L; Ermani M; Cavaletti G; Zambello R
J Peripher Nerv Syst; 2013 Mar; 18(1):19-24. PubMed ID: 23521639
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic dermatosis complicating lenalidomide therapy.
Thieu KP; Rosenbach M; Xu X; Kist JM
J Am Acad Dermatol; 2009 Oct; 61(4):709-10. PubMed ID: 19577327
[TBL] [Abstract][Full Text] [Related]
9. Recalcitrant pyoderma gangrenosum treated with thalidomide.
Federman GL; Federman DG
Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic agents for the management of patients with multiple myeloma and renal impairment.
Chanan-Khan AA; San Miguel JF; Jagannath S; Ludwig H; Dimopoulos MA
Clin Cancer Res; 2012 Apr; 18(8):2145-63. PubMed ID: 22328563
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide and lenalidomide in the treatment of multiple myeloma.
Kumar S; Rajkumar SV
Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
[TBL] [Abstract][Full Text] [Related]
12. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma.
Ahmad K; Ramsay B
Clin Exp Dermatol; 2009 Jan; 34(1):46-8. PubMed ID: 18627386
[TBL] [Abstract][Full Text] [Related]
13. Novel immunomodulatory compounds in multiple myeloma.
Saini N; Mahindra A
Expert Opin Investig Drugs; 2013 Feb; 22(2):207-15. PubMed ID: 23265189
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide in multiple myeloma.
Rajkumar SV
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients.
Amraoui K; Belhadj K; Maître B; Jannière-Nartey C; Dupuis J
Eur Respir Rev; 2013 Mar; 22(127):93-5. PubMed ID: 23457172
[No Abstract] [Full Text] [Related]
17. Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
Sviggum HP; Davis MD; Rajkumar SV; Dispenzieri A
Arch Dermatol; 2006 Oct; 142(10):1298-302. PubMed ID: 17043184
[TBL] [Abstract][Full Text] [Related]
18. [Pyoderma gangrenosum with aseptic spleen abscess].
Brahimi N; Maubec E; Boccara O; Marinho E; Valeyrie-Allanore L; Lecaille C; Sebban V; Hersent B; Picard-Dahan C; Descamps V; Crickx B
Ann Dermatol Venereol; 2009 Jan; 136(1):46-9. PubMed ID: 19171230
[TBL] [Abstract][Full Text] [Related]
19. Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone.
Montagnese F; Portaro S; Musumeci O; Migliorato A; Moggio M; Fagiolari G; Rodolico C
Muscle Nerve; 2015 Jun; 51(6):934-5. PubMed ID: 25524603
[No Abstract] [Full Text] [Related]
20. Treatment of multiple myeloma: thalidomide-, bortezomib-, and lenalidomide-induced peripheral neuropathy.
Koeppen S
Oncol Res Treat; 2014; 37(9):506-13. PubMed ID: 25231692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
